港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

藥明合聯

41.150

-1.700-3.97%

成交量：1,177.16萬

成交額：4.82億

市值：494.21億

市盈率：43.27

高：42.550

開：41.600

低：39.650

收：42.850

資料載入中...

總覽公司新聞公告

港股異動 | 藥明合聯(02268)漲超4% 去年純利同比大增277% 公司訂單儲備充足

異動解讀 | 藥明合聯盤中大漲5%，交銀國際上調目標價至51港元

異動解讀 | 藥明合聯盤中大漲5%，交銀國際上調目標價至51港元

【券商聚焦】信達證券：藥明合聯(02268)訂單儲備充足今年實現持續高增長確定性較高

交銀國際：升藥明合聯(02268)目標價至51港元行業高景氣度+CRDMO模式優勢持續驅動業績強勁增長

藥明合聯(02268)漲超4% 去年財報樂觀績後獲多家大行調升目標價

直擊業績會｜藥明合聯2024年歸母淨利潤“狂飆”277% 維持今年35%收入增幅預測不變

每日经济新闻

野村：升藥明合聯目標價至49.76港元去年業績超預期

野村：升藥明合聯(02268)目標價至49.76港元去年業績超預期

藥明合聯2024年業績亮眼，淨利潤同比增長277.2%

每日经济新闻

藥明合聯公佈2024年業績股東應占純利約10.7億元同比增長277.2%

藥明合聯2024年再創輝煌：業務強勁增長，財務業績亮眼

藥明合聯(02268)公佈2024年業績公司擁有人應占純利約10.7億元同比增長277.2%

ADC CRDMO龍頭藥明合聯(02268)業績“封神”：營收破40億！暴漲90.8% 淨利狂飆277%

智通财经网

藥明合聯03月20日主力淨流入534萬元散户資金拋售

AI 賦能+政策支持，港股創新藥迎來“黃金佈局期”

中國藥明康德去年淨利同比微降，預計持續經營業務收入今年重回雙位數增長

智通港股解盤 | 兩大利好直接引爆“東昇” 育兒補貼刺激消費新預期

藥明合聯03月14日主力淨流入137萬元散戶資金拋售

藥明系集體炒高藥明合聯(02268.HK)指在“2025亞太生物製藥卓越獎”奪四獎

阿斯达克财经

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02268/news?page=3"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02268","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"藥明合聯","latestPrice":41.15,"timestamp":1743667696033,"preClose":42.85,"halted":0,"volume":11771578,"delay":0,"floatShares":1201000000,"shares":1201000000,"eps":0.9510180990973479,"marketStatus":"休市中","change":-1.7,"latestTime":"04-03 16:08:16","open":41.6,"high":42.55,"low":39.65,"amount":482354622,"amplitude":0.067678,"askPrice":41.2,"askSize":500,"bidPrice":41.15,"bidSize":12000,"shortable":3,"etf":0,"ttmEps":0.8844111999362468,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1743989400000},"marketStatusCode":7,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":42.85,"openAndCloseTimeList":[[1743643800000,1743652800000],[1743656400000,1743667200000]],"volumeRatio":0.5754415858536063,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02268\",,,,,undefined,":{"symbol":"02268","floatShares":1201000000,"roa":"7.19%","roe":"17.69%","lyrEps":0.951018,"volumeRatio":0.5754415858536063,"shares":1201000000,"dividePrice":0,"high":42.55,"amplitude":0.067678,"preClose":42.85,"low":39.65,"week52Low":14.08,"pbRate":"6.99","psRate":"11.45","week52High":49.5,"institutionHeld":0,"latestPrice":41.15,"committee":0.92,"eps":0.9510180990973479,"divideRate":0,"volume":11771578,"delay":0,"ttmEps":0.8844111999362468,"open":41.6,"prevYearClose":30.65,"prevWeekClose":45.7,"prevMonthClose":44.4,"prevQuarterClose":44.4,"fiveDayClose":44.5,"twentyDayClose":34.8,"sixtyDayClose":29.9},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02268\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522902358","title":"港股異動 | 藥明合聯(02268)漲超4% 去年純利同比大增277% 公司訂單儲備充足","url":"https://stock-news.laohu8.com/highlight/detail?id=2522902358","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522902358?lang=zh_tw&edition=fundamental","pubTime":"2025-03-26 14:48","pubTimestamp":1742971705,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，药明合联涨超4%，截至发稿，涨4.25%，报41.7港元，成交额1.48亿港元。消息面上，药明合联近期公布2024年业绩，收益约40.52亿元，同比增长90.8%；毛利约12.4亿元，同比增长121.6%；公司拥有人应占纯利约10.7亿元，同比增长277.2%；经调整纯利同比增长184.8%至11.74亿元。从订单储备来看，截至 2024 年底，公司未完成订单总额达到 9.91 亿美元，同比增长 71%，其中新签合同金额与未完成订单增速保持同步，北美地区的未完成订单总额同比增长超 100%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1267895.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999014674.SGD","02268","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"1159929750","title":"異動解讀 | 藥明合聯盤中大漲5%，交銀國際上調目標價至51港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159929750","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159929750?lang=zh_tw&edition=fundamental","pubTime":"2025-03-26 10:32","pubTimestamp":1742956350,"startTime":"0","endTime":"0","summary":"3月26日周三盘中，药明合联股价大涨5%，引发市场关注。这一涨势与交银国际最新发布的研报密切相关。交银国际在研报中上调了药明合联的目标价至51港元，并对公司2025-26年经调整净利润预测上调7-10%。2024年，公司收入和经调整净利润分别同比增长91%和185%，超出此前盈利预告。展望2025年，药明合联管理层指引收入增长35%，并预计利润率将保持稳定，甚至有望进一步提升。这些积极因素共同推动了投资者信心，促使股价上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02268"],"gpt_icon":0},{"id":"1159968125","title":"異動解讀 | 藥明合聯盤中大漲5%，交銀國際上調目標價至51港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159968125","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1159968125?lang=zh_tw&edition=fundamental","pubTime":"2025-03-26 10:32","pubTimestamp":1742956346,"startTime":"0","endTime":"0","summary":"周三盘中，药明合联股价大涨5%，引起市场广泛关注。这一涨幅与交银国际最新发布的研报密切相关，该研报上调了药明合联的目标价，并对公司未来发展前景给予积极评价。据悉，交银国际基于药明合联2024年强劲业绩和管理层指引，将公司2025-26年经调整净利润预测上调7-10%，同时将目标价上调至51港元。展望2025年，药明合联管理层指引收入增长35%，利润率有望保持稳定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 药明合联盘中大涨5%，交银国际上调目标价至51港元","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02268"],"gpt_icon":0},{"id":"2522851866","title":"【券商聚焦】信達證券：藥明合聯(02268)訂單儲備充足 今年實現持續高增長確定性較高","url":"https://stock-news.laohu8.com/highlight/detail?id=2522851866","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522851866?lang=zh_tw&edition=fundamental","pubTime":"2025-03-26 10:31","pubTimestamp":1742956289,"startTime":"0","endTime":"0","summary":"金吾财讯 | 信达证券发研报指，2024年药明合联 实现营业收入40.52亿元，同比增长91%；实现毛利润12.40亿元，同比增长122%，对应毛利率达到30.6%；实现净利润10.69亿元，同比增长277%，对应净利率达到26.4%；实现经调整净利润11.74亿元，同比增长185%，对应经调整净利率达到29.0%；实现经调整净利润9.92亿元，同比增长171%，对应经调整净利率达到24.5%。该行认为，公司订单储备充足，2025年实现持续高增长的确定性较高。","market":"other","thumbnail":"https://static.szfiu.com/news/20250106/ZGNkM2E3NDVjMTk0N2Q5ZDk4NjYxNjc1YjA4NjMzOTA5MjkwMDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZGNkM2E3NDVjMTk0N2Q5ZDk4NjYxNjc1YjA4NjMzOTA5MjkwMDE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1955919","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2488822045.USD","BK0276","02268","601059","BK1141","SG9999014674.SGD"],"gpt_icon":0},{"id":"2522863978","title":"交銀國際：升藥明合聯(02268)目標價至51港元 行業高景氣度+CRDMO模式優勢持續驅動業績強勁增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2522863978","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522863978?lang=zh_tw&edition=fundamental","pubTime":"2025-03-26 10:24","pubTimestamp":1742955849,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，基于2024年强劲业绩和管理层指引，该行上调药明合联2025-26E经调整净利润预测7-10%、上调DCF目标价至51港元。公司2024年收入增长几乎翻倍、新签53个订单、北美业务快速扩张，体现ADC研发外包行业的持续高景气度和公司CRDMO模式的服务质量优势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1267761.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268"],"gpt_icon":0},{"id":"2522866385","title":"藥明合聯(02268)漲超4% 去年財報樂觀 績後獲多家大行調升目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=2522866385","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522866385?lang=zh_tw&edition=fundamental","pubTime":"2025-03-26 10:17","pubTimestamp":1742955447,"startTime":"0","endTime":"0","summary":"金吾财讯 | 药明合联 早盘股价走势强劲，截至发稿，报41.75港元，涨4.38%，成交额5605.49万港元。经调整纯利11.74亿元，同比增长184.8%。期内收益40.52亿，同比增加90.8%；毛利12.4亿元，上升121.6%。该行上调2025-26E经调整净利润预测7-10%、上调DCF目标价至51港元。另外，野村表示，药明合联财报反映集团去年下半年的收入及净利润大幅上升，按年分别增111%和447%。认为药明合联的财报相当乐观，重申对其“买入”评级，目标价由42.5港元上调至49.76港元。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg"],"rights":null,"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1955917","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"gpt_icon":0},{"id":"2522049569","title":"直擊業績會｜藥明合聯2024年歸母淨利潤“狂飆”277% 維持今年35%收入增幅預測不變","url":"https://stock-news.laohu8.com/highlight/detail?id=2522049569","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522049569?lang=zh_tw&edition=fundamental","pubTime":"2025-03-25 18:10","pubTimestamp":1742897404,"startTime":"0","endTime":"0","summary":"按照此前药明合联发布的业绩指引，公司今年收入预计将实现35%增长。在3月25日的业绩沟通会上，药明合联对此表示，公司需要确保完成业绩指引，因此目前不会改变这一增幅预测。3月24日晚间，药明合联发布2024年业绩公告。北美地区给药明合联的收入贡献占比也持续提升，从2023年的约40%提升至去年的50%。从利润率来看，药明合联2024年的毛利率和经调整净利润率分别同比提升了4.3个百分点和7.3个百分点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032518111597228ee2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032518111597228ee2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268"],"gpt_icon":0},{"id":"2522483052","title":"野村：升藥明合聯目標價至49.76港元 去年業績超預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2522483052","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522483052?lang=zh_tw&edition=fundamental","pubTime":"2025-03-25 11:36","pubTimestamp":1742873760,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　野村发布研报称，将药明合联（02268）目标价从42.5港元上调17%至49.76港元，评级为“买入”。考虑到全球对ADC药物的需求旺盛，该行预计2025财年将持续强劲增长。报告指，药明合联2024财年业绩超预期，收入同比增长91%，较机构及该行预测高出15%及19%，利润同比增长277%，较机构及该行预测高出18%及124%。2024年下半年收入及净利增长强劲，同比分别增长111%及447%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：史丽君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2025-03-25/doc-ineqvvkv9987726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02268"],"gpt_icon":0},{"id":"2522246059","title":"野村：升藥明合聯(02268)目標價至49.76港元 去年業績超預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2522246059","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522246059?lang=zh_tw&edition=fundamental","pubTime":"2025-03-25 11:11","pubTimestamp":1742872293,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，野村发布研报称，将药明合联(02268)目标价从42.5港元上调17%至49.76港元，评级为“买入”。考虑到全球对ADC药物的需求旺盛，该行预计2025财年将持续强劲增长。报告指，药明合联2024财年业绩超预期，收入同比增长91%，较机构及该行预测高出15%及19%，利润同比增长277%，较机构及该行预测高出18%及124%。2024年下半年收入及净利增长强劲，同比分别增长111%及447%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1266991.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268"],"gpt_icon":0},{"id":"2522039432","title":"藥明合聯2024年業績亮眼，淨利潤同比增長277.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2522039432","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522039432?lang=zh_tw&edition=fundamental","pubTime":"2025-03-25 09:15","pubTimestamp":1742865338,"startTime":"0","endTime":"0","summary":"药明合联公布2024年度业绩，营业收入同比增长90.8%，至40.52亿元；净利润同比增长277.2%，至12.4亿元。此前同属药明系的药明康德发布2024年业绩后大涨，其2024年营收同比增长5.2%（剔除去年新冠商业化项目），经调整Non-IFRS归母净利润105.8亿元，净利润率创历史新高。恒生医药ETF（159892）持仓药明康德、药明生物、药明合联等知名标的；近期处于年报密集披露期，医药行业整体业绩呈现良好复苏态势，有望推动估值修复。恒生医药ETF联接（A类：016970，C类：016971）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032509185594bfaf6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025032509185594bfaf6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02359","02268"],"gpt_icon":0},{"id":"2522103564","title":"藥明合聯公佈2024年業績 股東應占純利約10.7億元同比增長277.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2522103564","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522103564?lang=zh_tw&edition=fundamental","pubTime":"2025-03-25 08:50","pubTimestamp":1742863800,"startTime":"0","endTime":"0","summary":"　　药明合联公布2024年业绩，收益约40.52亿元，同比增长90.8%。公司拥有人应占纯利约10.7亿元，同比增长277.2%。经调整纯利同比增长184.8%至11.74亿元。基本每股盈利0.89元。　　该集团的CRDMO业务于2023年及2024年呈现强劲势头，业务持续积极扩展，全球客户对其服务的需求亦有所增加。截至2024年12月31日，凭借其全面的CRDMO能力以及配备从药物发现到商业化的“一站式”功能的设施，集团已通过提供综合服务累计赋能全球499名客户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-03-25/doc-ineqvkuu7160529.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SG9999014674.SGD","LU2488822045.USD","BK1141","02268"],"gpt_icon":0},{"id":"2521771062","title":"藥明合聯2024年再創輝煌：業務強勁增長，財務業績亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=2521771062","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521771062?lang=zh_tw&edition=fundamental","pubTime":"2025-03-24 22:33","pubTimestamp":1742826780,"startTime":"0","endTime":"0","summary":"\" 财务亮点 - 营业收入：截至2024年12月31日，本集团收入同比增长90.8%，至人民币40.52亿元。2024年集团净利率达26.4%，较2023年提升13.0个百分点。截至报告期末，药明合联赋能客户实现对外授权的资产均处于积极开发状态。凭借平台化优势，集团在2024年持续赋能客户，并成为协助客户取得IND获批数量全球最多的ADC CRDMO，以持续巩固行业领导地位。为应对快速增长的市场需求，集团宣布计划在无锡基地新增两条制剂生产线。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4648117_ZH48117_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["ADC","ESG","LU0256331488.USD","LU2308191902.HKD","LU2211817866.USD","DAR","LU1721429402.USD","LU2380233275.USD","LU2488822045.USD","SG9999014674.SGD","02268","BK1141","BK4080","LU1721429741.USD","BK4189","BK4231"],"gpt_icon":1},{"id":"2521249627","title":"藥明合聯(02268)公佈2024年業績 公司擁有人應占純利約10.7億元 同比增長277.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2521249627","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521249627?lang=zh_tw&edition=fundamental","pubTime":"2025-03-24 21:34","pubTimestamp":1742823298,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明合联 公布2024年业绩，收益约40.52亿元，同比增长90.8%。经调整纯利同比增长184.8%至11.74亿元。基本每股盈利0.89元。该集团的CRDMO业务于2023年及2024年呈现强劲势头，业务持续积极扩展，全球客户对其服务的需求亦有所增加。截至2024年12月31日，凭借其全面的CRDMO能力以及配备从药物发现到商业化的“一站式”功能的设施，集团已通过提供综合服务累计赋能全球499名客户。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1266751.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268","BK1141","LU2488822045.USD","SG9999014674.SGD"],"gpt_icon":0},{"id":"2521725952","title":"ADC CRDMO龍頭藥明合聯(02268)業績“封神”：營收破40億！暴漲90.8% 淨利狂飆277%","url":"https://stock-news.laohu8.com/highlight/detail?id=2521725952","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521725952?lang=zh_tw&edition=fundamental","pubTime":"2025-03-24 20:31","pubTimestamp":1742819460,"startTime":"0","endTime":"0","summary":"本次的全年业绩公告中，药明合联2024年全年营业收入达40.52亿元人民币，同比增长90.8%;毛利润达12.40亿元人民币，增速高达121.6%，毛利率从2023年的26.3%跃升至30.6%，盈利能力显著提升;净利润更是同比激增277%至10.70亿元，净利润率从13.4%提升至26.4%。财报显示，截至报告期，药明合联全球客户总数扩大到499家，2024年新增154家客户。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1266678.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["ADC","02268"],"gpt_icon":0},{"id":"2520438721","title":"藥明合聯03月20日主力淨流入534萬元 散户資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2520438721","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520438721?lang=zh_tw&edition=fundamental","pubTime":"2025-03-20 16:15","pubTimestamp":1742458523,"startTime":"0","endTime":"0","summary":"03月20日, 药明合联股价涨0.77%，报收45.90元，成交金额2.78亿元，换手率0.51%，振幅4.94%，量比1.09。药明合联今日主力资金净流入534万元，上一交易日主力净流出612万元。该股近5个交易日上涨31.38%，主力资金累计净流入478万元；近20日主力资金累计净流入1354万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250320164932a69d5174&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250320164932a69d5174&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","SG9999014674.SGD","BK1141","02268"],"gpt_icon":0},{"id":"2520667747","title":"AI 賦能+政策支持，港股創新藥迎來“黃金佈局期”","url":"https://stock-news.laohu8.com/highlight/detail?id=2520667747","media":"万家基金","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520667747?lang=zh_tw&edition=fundamental","pubTime":"2025-03-18 11:27","pubTimestamp":1742268442,"startTime":"0","endTime":"0","summary":"据报道，医疗卫生军团将重点构建AI辅助诊断解决方案体系，推动医疗大模型在临床场景的应用。受AI热潮催化、政策利好不断等因素影响，近来创新药市场的增长势头良好，港股创新药板块的表现也较为强劲。AI 赋能是创新药的另一大看点。AI通过强大的计算能力和数据处理能力，可以加速药物研发，降低研发成本，有助于缩短新药上市时间，还能提高新药的成功率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250318112520a699ef16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250318112520a699ef16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","06160","09995","BK1191","HSCEI","01558","02096","01093","BK1588","03692","09688","09969","BK1574","01513","02196","03759","06821","06185","01877","HSTECH","01530","02186","00867","01177","06978","BK1587","00512","02359","00013","02607","01548","09926","03347","02269","06127","01801","BK1161"],"gpt_icon":1},{"id":"2520333522","title":"中國藥明康德去年淨利同比微降，預計持續經營業務收入今年重回雙位數增長","url":"https://stock-news.laohu8.com/highlight/detail?id=2520333522","media":"路透中文","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520333522?lang=zh_tw&edition=fundamental","pubTime":"2025-03-17 21:43","pubTimestamp":1742219036,"startTime":"0","endTime":"0","summary":"路透北京3月17日 - 中国药物代工研发巨头--药明康德603259.SS2359.HK周一公布，2024年净利润和营收同比微降，但预计持续经营业务收入今年同比将转升、“重回双位数增长”；同时称拟回购10亿元公司股份，用于减少注册资本。截至2024年末，公司持续经营业务在手订单493.1亿元，同比增长47%。生物安全法案最终并未被纳入2025财年国防授权法案，但这并不意味着药明康德和其他中国CDMO同业面临的外部风险已经全部解除。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250317:nL4T3Q00CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1997245177.USD","LU1046422090.SGD","LU0823426308.USD","02268","BK1610","BK1521","LU0327786744.USD","LU1997245094.SGD","LU2045819591.USD","LU2242644610.SGD","LU1688375341.USD","LU0140636845.USD","LU0516422366.SGD","LU0516423091.SGD","LU0359201612.USD","LU0856984785.SGD","LU0039217434.USD","LU0456827905.SGD","LU0819121731.USD","BK1583","LU1880383366.USD","LU0516422952.EUR","LU0823426480.USD","LU0417516738.SGD","LU1794554557.SGD","603259","IE00B0JY6N72.USD","LU0320764599.SGD","LU2488822045.USD","LU0348825331.USD","LU0052750758.USD","BK1589","LU0181495838.USD","LU0051755006.USD","LU0043850808.USD","BK1141","LU2039709279.SGD","LU0516422440.USD","BK1576","LU0417516902.SGD","LU1720050803.USD","LU1242518857.USD","LU0307460666.USD","LU0516423174.USD","LU0348735423.USD","02359","LU0326950275.SGD","LU0588546209.SGD","SG9999002463.SGD"],"gpt_icon":1},{"id":"2519808094","title":"智通港股解盤 | 兩大利好直接引爆“東昇” 育兒補貼刺激消費新預期","url":"https://stock-news.laohu8.com/highlight/detail?id=2519808094","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519808094?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 19:42","pubTimestamp":1741952566,"startTime":"0","endTime":"0","summary":"中国市场均涨幅超2%。三方强调终止所有非法单边制裁的必要性。外资大行普遍将黄金价格从每盎司2890美元大幅上调至3100美元。3月13日，内蒙古呼和浩特市发布落实《关于促进人口集聚推动人口高质量发展的实施意见》育儿补贴项目实施细则及服务流程。从人口增加这个维度来看，消费这块的预期就会加强。国新办将于3月17日下午3时举行新闻发布会，介绍提振消费有关情况，重要部门负责人将出席。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1262223.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0327786744.USD","LU0326950275.SGD","LU0359201612.USD","LU0348825331.USD","LU0819121731.USD","LU1242518931.SGD","BK1141","LU1880383366.USD","BK1576","LU1794554557.SGD","LU0979878070.USD","LU0456846285.SGD","HSCEI","LU0052750758.USD","03759","BK1191","BK1521","LU0043850808.USD","LU0456827905.SGD","LU0307460666.USD","LU0708995583.HKD","LU0856984785.SGD","LU2039709279.SGD","LU0359202008.SGD","LU2488822045.USD","BK1610","LU0516423091.SGD","LU0823426480.USD","YANG","HSTECH","LU0348735423.USD","LU0039217434.USD","LU0181495838.USD","LU0572944931.SGD","LU0051755006.USD","LU0417516902.SGD","02268","BK1589","LU0516422366.SGD","BK4614","SG9999002562.SGD","LU0417516738.SGD","06821","IE00B0JY6N72.USD","LU0320764599.SGD","SG9999014674.SGD","LU0516422952.EUR","SG9999002463.SGD"],"gpt_icon":1},{"id":"2519765628","title":"藥明合聯03月14日主力淨流入137萬元 散戶資金拋售","url":"https://stock-news.laohu8.com/highlight/detail?id=2519765628","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519765628?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 16:16","pubTimestamp":1741940188,"startTime":"0","endTime":"0","summary":"03月14日, 药明合联股价涨10.84%，报收38.85元，成交金额2.85亿元，换手率0.62%，振幅13.41%，量比2.02。药明合联今日主力资金净流入137万元，上一交易日主力净流出449万元。该股近5个交易日上涨9.94%，主力资金累计净流出616万元；近20日主力资金累计净流入2303万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314165254ab653f13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250314165254ab653f13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","SG9999014674.SGD","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"2519181682","title":"藥明系集體炒高  藥明合聯(02268.HK)指在“2025亞太生物製藥卓越獎”奪四獎","url":"https://stock-news.laohu8.com/highlight/detail?id=2519181682","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519181682?lang=zh_tw&edition=fundamental","pubTime":"2025-03-14 10:31","pubTimestamp":1741919460,"startTime":"0","endTime":"0","summary":"药明系今早受捧，药明合联抽上近10%报38.55元；药明生物股价弹高10.3%报25.7元；药明康德扬4.2%。药明合联公布，宣布公司在“2025亚太生物制药卓越奖”中获取四项奖项。“亚太生物制药卓越奖”旨在评选出每年在生物医药行业表现卓越的企业。这一系列奖项荣誉，充分肯定了药明合联在ADC偶联药物领域的技术领先地位、公司从早期发现到商业化生产的一体化综合性CRDMO能力，以及药明合联始终以高品质服务持续赋能全球客户的承诺。沽空资料截至 2025-03-13 16:25。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20211229100131212_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20211229100131212_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1424641/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","SG9999014674.SGD","02268","LU2488822045.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02268\",params:#limit:5,,,undefined,":[{"date":"2025-03-24","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-20","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724117400000,"name":null,"time":"","dateTimestamp":1724083200000,"actualEps":null},{"date":"2024-03-25","symbol":"02268","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02268\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02268\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3889,"buy":0.5556,"hold":0.0556,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":18,"updateTime":1743091200000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02268\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02268","date":"2025-04-03","current":43.121995,"percent":0.439252,"low":0.407466,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"high":153.052589,"avg":46.164517,"sd":42.328118,"marketCap":49380552191},"quantilePoints":[{"date":"2020-04-09","current":0.444116,"twenty":2.759621,"median":7.82388,"eighty":11.01076,"marketCap":323186685},{"date":"2020-04-17","current":0.446187,"twenty":2.745207,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-04-24","current":0.446702,"twenty":2.734879,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-04-29","current":0.44639,"twenty":2.727395,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-05-08","current":0.446161,"twenty":2.71703,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-05-15","current":0.447931,"twenty":2.704934,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-05-22","current":0.449375,"twenty":2.687419,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-05-29","current":0.450088,"twenty":2.678738,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-06-05","current":0.44683,"twenty":2.666003,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-06-12","current":0.446873,"twenty":2.652949,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-06-19","current":0.446059,"twenty":2.62708,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-06-26","current":0.446464,"twenty":2.610591,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-07-03","current":0.445777,"twenty":2.573756,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-07-10","current":0.441566,"twenty":2.54079,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-07-17","current":0.440865,"twenty":2.474175,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-07-24","current":0.442598,"twenty":2.408815,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-07-31","current":0.440015,"twenty":2.351114,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-08-07","current":0.439541,"twenty":2.260124,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-08-14","current":0.438441,"twenty":0.452125,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-08-21","current":0.436461,"twenty":0.449515,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-08-28","current":0.43308,"twenty":0.448387,"median":7.828992,"eighty":11.018,"marketCap":323186685},{"date":"2020-09-04","current":0.431618,"twenty":0.447817,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-09-11","current":0.431156,"twenty":0.447535,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-09-18","current":0.427016,"twenty":0.447373,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-09-25","current":0.430436,"twenty":0.447153,"median":7.826865,"eighty":11.015587,"marketCap":323186685},{"date":"2020-09-30","current":0.428392,"twenty":0.446995,"median":7.824737,"eighty":11.013173,"marketCap":323186685},{"date":"2020-10-09","current":0.422312,"twenty":0.446839,"median":7.815551,"eighty":11.015587,"marketCap":323186685},{"date":"2020-10-16","current":0.422486,"twenty":0.446689,"median":7.778238,"eighty":11.015587,"marketCap":323186685},{"date":"2020-10-23","current":0.421832,"twenty":0.446509,"median":7.763554,"eighty":11.013173,"marketCap":323186685},{"date":"2020-10-30","current":0.421767,"twenty":0.446296,"median":7.728277,"eighty":11.015587,"marketCap":323186685},{"date":"2020-11-06","current":0.416892,"twenty":0.446096,"median":7.681665,"eighty":11.015587,"marketCap":323186685},{"date":"2020-11-13","current":0.416542,"twenty":0.445828,"median":7.62168,"eighty":11.015587,"marketCap":323186685},{"date":"2020-11-20","current":0.413946,"twenty":0.445667,"median":7.588964,"eighty":11.015587,"marketCap":323186685},{"date":"2020-11-27","current":0.414916,"twenty":0.445574,"median":7.400318,"eighty":11.015587,"marketCap":323186685},{"date":"2020-12-04","current":0.411952,"twenty":0.44527,"median":7.31626,"eighty":11.015587,"marketCap":323186685},{"date":"2020-12-11","current":0.41294,"twenty":0.44498,"median":7.224146,"eighty":11.015587,"marketCap":323186685},{"date":"2020-12-18","current":0.412272,"twenty":0.444321,"median":7.177259,"eighty":11.047512,"marketCap":323186685},{"date":"2020-12-24","current":0.411847,"twenty":0.443892,"median":6.957959,"eighty":11.047512,"marketCap":323186685},{"date":"2020-12-31","current":0.411678,"twenty":0.44363,"median":6.764797,"eighty":11.047512,"marketCap":323186685},{"date":"2021-01-08","current":0.408416,"twenty":0.443491,"median":6.650061,"eighty":11.067383,"marketCap":323186685},{"date":"2021-01-15","current":0.408583,"twenty":0.442598,"median":6.55329,"eighty":11.072351,"marketCap":323186685},{"date":"2021-01-22","current":0.408755,"twenty":0.442234,"median":6.512372,"eighty":11.072351,"marketCap":323186685},{"date":"2023-11-17","current":130.035431,"twenty":0.435785,"median":0.444801,"eighty":2.787891,"marketCap":32996488000},{"date":"2023-11-24","current":133.579843,"twenty":0.435785,"median":0.444801,"eighty":2.810425,"marketCap":34174934000},{"date":"2023-12-01","current":147.707211,"twenty":0.435785,"median":0.444801,"eighty":2.852893,"marketCap":37945961200},{"date":"2023-12-08","current":132.646927,"twenty":0.435785,"median":0.444801,"eighty":2.935117,"marketCap":33939244800},{"date":"2023-12-15","current":138.75437,"twenty":0.435785,"median":0.444801,"eighty":3.039251,"marketCap":35706913800},{"date":"2023-12-22","current":153.052589,"twenty":0.435785,"median":0.444801,"eighty":3.172504,"marketCap":39360096400},{"date":"2023-12-29","current":145.85951,"twenty":0.435785,"median":0.444801,"eighty":3.326638,"marketCap":37710272000},{"date":"2024-01-05","current":142.305018,"twenty":0.435785,"median":0.444801,"eighty":3.599996,"marketCap":36531826000},{"date":"2024-01-12","current":138.558869,"twenty":0.435785,"median":0.444801,"eighty":3.622774,"marketCap":35589069200},{"date":"2024-01-19","current":141.046625,"twenty":0.435785,"median":0.444801,"eighty":3.635946,"marketCap":36178292200},{"date":"2024-01-26","current":116.23004,"twenty":0.435785,"median":0.444801,"eighty":3.642902,"marketCap":29696839200},{"date":"2024-02-02","current":82.111439,"twenty":0.435785,"median":0.444801,"eighty":3.654128,"marketCap":20952769880},{"date":"2024-02-09","current":67.278987,"twenty":0.435825,"median":0.445043,"eighty":3.68657,"marketCap":17252449440},{"date":"2024-02-16","current":66.713097,"twenty":0.435798,"median":0.44487,"eighty":3.704054,"marketCap":17111035920},{"date":"2024-02-23","current":82.124312,"twenty":0.435798,"median":0.44487,"eighty":3.728385,"marketCap":20952769880},{"date":"2024-03-01","current":86.135235,"twenty":0.435812,"median":0.444939,"eighty":3.767614,"marketCap":21989802360},{"date":"2024-03-08","current":96.662972,"twenty":0.435812,"median":0.444939,"eighty":3.804363,"marketCap":24688443700},{"date":"2024-03-15","current":72.134287,"twenty":0.435812,"median":0.444939,"eighty":3.87411,"marketCap":18407326520},{"date":"2024-03-22","current":82.739174,"twenty":0.435812,"median":0.444939,"eighty":3.907844,"marketCap":21094183400},{"date":"2024-03-28","current":70.236298,"twenty":0.435812,"median":0.444939,"eighty":3.924107,"marketCap":21565561800},{"date":"2024-04-05","current":69.514463,"twenty":0.435772,"median":0.444721,"eighty":3.932321,"marketCap":21329872600},{"date":"2024-04-12","current":72.929575,"twenty":0.435785,"median":0.444801,"eighty":3.970214,"marketCap":22390474000},{"date":"2024-04-19","current":66.691535,"twenty":0.435785,"median":0.444801,"eighty":4.01279,"marketCap":20457822560},{"date":"2024-04-26","current":78.851628,"twenty":0.435812,"median":0.444939,"eighty":62.837086,"marketCap":24158143000},{"date":"2024-05-03","current":79.483533,"twenty":0.435812,"median":0.444939,"eighty":66.70016,"marketCap":24334909900},{"date":"2024-05-10","current":73.189732,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":22461180760},{"date":"2024-05-17","current":65.221538,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19986444160},{"date":"2024-05-24","current":58.278715,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17818103520},{"date":"2024-05-31","current":59.948577,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":18347300940},{"date":"2024-06-07","current":58.299117,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":17820354960},{"date":"2024-06-14","current":64.156468,"twenty":0.435812,"median":0.444939,"eighty":68.608876,"marketCap":19592809620},{"date":"2024-06-21","current":70.500097,"twenty":0.435812,"median":0.444939,"eighty":69.593748,"marketCap":21485024730},{"date":"2024-06-28","current":68.013259,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":20718557850},{"date":"2024-07-05","current":61.893714,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":18850294830},{"date":"2024-07-12","current":63.530585,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":19377240810},{"date":"2024-07-19","current":56.933019,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17365265250},{"date":"2024-07-26","current":56.800526,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":17389217340},{"date":"2024-08-02","current":69.358964,"twenty":0.435812,"median":0.444939,"eighty":70.441134,"marketCap":21221551740},{"date":"2024-08-09","current":72.710245,"twenty":0.435812,"median":0.444939,"eighty":70.597189,"marketCap":22395204150},{"date":"2024-08-16","current":74.003491,"twenty":0.435812,"median":0.444939,"eighty":70.930659,"marketCap":22802389680},{"date":"2024-08-23","current":35.050376,"twenty":0.435812,"median":0.44524,"eighty":71.736965,"marketCap":22742129354},{"date":"2024-08-30","current":36.779427,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":24024219892},{"date":"2024-09-06","current":36.193339,"twenty":0.435812,"median":0.445278,"eighty":71.736965,"marketCap":23652773101},{"date":"2024-09-13","current":36.950123,"twenty":0.435812,"median":0.445611,"eighty":71.736965,"marketCap":24084130665},{"date":"2024-09-20","current":36.912594,"twenty":0.435798,"median":0.445732,"eighty":71.812082,"marketCap":24203952211},{"date":"2024-09-27","current":41.596291,"twenty":0.435798,"median":0.446064,"eighty":71.812082,"marketCap":27439133942},{"date":"2024-10-04","current":49.267448,"twenty":0.435798,"median":0.446181,"eighty":71.812082,"marketCap":32351817312},{"date":"2024-10-10","current":43.61955,"twenty":0.435812,"median":0.446472,"eighty":71.736965,"marketCap":28457617080},{"date":"2024-10-18","current":43.201999,"twenty":0.435798,"median":0.446694,"eighty":71.812082,"marketCap":28038241670},{"date":"2024-10-25","current":43.020102,"twenty":0.435798,"median":0.446852,"eighty":71.812082,"marketCap":27918420124},{"date":"2024-11-01","current":41.699543,"twenty":0.435798,"median":0.446999,"eighty":71.812082,"marketCap":27079669305},{"date":"2024-11-08","current":47.130705,"twenty":0.435852,"median":0.447279,"eighty":71.812082,"marketCap":30374761809},{"date":"2024-11-15","current":46.740281,"twenty":0.435852,"median":0.44753,"eighty":71.812082,"marketCap":29895475627},{"date":"2024-11-22","current":46.01742,"twenty":0.435852,"median":0.447785,"eighty":71.812082,"marketCap":29416189444},{"date":"2024-11-29","current":51.670123,"twenty":0.435852,"median":0.448371,"eighty":71.812082,"marketCap":33010835812},{"date":"2024-12-06","current":54.048034,"twenty":0.435852,"median":0.449445,"eighty":71.812082,"marketCap":34448694360},{"date":"2024-12-13","current":58.707371,"twenty":0.435852,"median":0.45138,"eighty":71.812082,"marketCap":37384322227},{"date":"2024-12-20","current":60.54506,"twenty":0.435852,"median":35.016583,"eighty":71.812082,"marketCap":38342894592},{"date":"2024-12-27","current":58.22519,"twenty":0.435852,"median":35.863906,"eighty":71.812082,"marketCap":36845125272},{"date":"2025-01-03","current":57.033249,"twenty":0.435852,"median":36.241161,"eighty":71.812082,"marketCap":36126195998},{"date":"2025-01-10","current":62.66188,"twenty":0.435852,"median":36.730689,"eighty":71.812082,"marketCap":39541110048},{"date":"2025-01-17","current":54.642634,"twenty":0.436361,"median":37.212991,"eighty":71.812082,"marketCap":34508605132},{"date":"2025-01-24","current":54.868028,"twenty":0.436606,"median":39.470644,"eighty":71.812082,"marketCap":34868069769},{"date":"2025-01-28","current":52.331181,"twenty":0.436643,"median":41.238065,"eighty":71.736965,"marketCap":33430211222},{"date":"2025-02-07","current":57.910706,"twenty":0.437089,"median":42.380717,"eighty":71.8872,"marketCap":36785214499},{"date":"2025-02-14","current":56.82028,"twenty":0.437089,"median":43.020102,"eighty":71.8872,"marketCap":36006374452},{"date":"2025-02-21","current":70.802488,"twenty":0.437089,"median":44.139364,"eighty":71.8872,"marketCap":45112811918},{"date":"2025-02-28","current":60.65941,"twenty":0.437089,"median":45.078416,"eighty":71.8872,"marketCap":38522626910},{"date":"2025-03-07","current":67.088057,"twenty":0.437583,"median":46.607669,"eighty":71.962317,"marketCap":42776291779},{"date":"2025-03-14","current":72.98104,"twenty":0.438098,"median":47.703312,"eighty":71.990989,"marketCap":46550670465},{"date":"2025-03-21","current":80.244903,"twenty":0.438098,"median":49.592986,"eighty":72.978175,"marketCap":51163799971},{"date":"2025-03-28","current":47.906694,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":54840613248},{"date":"2025-04-03","current":43.121995,"twenty":0.438098,"median":49.821395,"eighty":72.98104,"marketCap":49380552191}],"updateTime":1743834317255}}}